Faculty profile

Jean-Philippe Lafrance

Back to faculty

ProfessorDépartement de pharmacologie et physiologieUniversité de Montréal

Jean-Philippe Lafrance

Professor

Département de pharmacologie et physiologie

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
6 publications in the last five years, latest in 2024.
Senior (last) author on 2 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

678

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université de Montréal profile.

Latest papers

Is health-related quality of life trajectory associated with dialysis modality choice in advanced chronic kidney disease?
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2024
Designing and validating a clinical decision support algorithm for diabetic nephroprotection in older patients.
BMJ health & care informatics · 2024 · senior author
Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study.
Kidney360 · 2023

All 46 publications

Latest funding

The KIdney aNd blooD prESsure ouTcomes - Determining best fOllow-up in hospitalized Children (KINDEST-DOC) study: A national study of the FILTR-CKD study group
CIHR · 2021 · Co-investigator
$1,074,825
Impact of COVID-19 on Patients Receiving Hemodialysis: The Quebec Renal Network (QRN) COVID-19 Study
CIHR · 2020 · Co-investigator
$476,333
Facilitating Cluster Trials in Dialysis: A National Workshop of Key Stakeholders
CIHR · 2015 · Co-investigator
$20,000

All 3 grants and awards

46 publications.

Is health-related quality of life trajectory associated with dialysis modality choice in advanced chronic kidney disease?

Morin C, Pichette M, Elftouh N, Imbeault B, Laurin LP, Lafrance JP, Goupil R, Nadeau-Fredette AC

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis20243 citations

DOI: 10.1177/08968608231217807 PMID: 38186013

Designing and validating a clinical decision support algorithm for diabetic nephroprotection in older patients.

Alsalemi N, Sadowski C, Elftouh N, Kilpatrick K, Houle S, Leclerc S, Fernandez N, Lafrance JP

BMJ health & care informatics20241 citationsSenior authorOpen Access

DOI: 10.1136/bmjhci-2023-100869 PMID: 39209331

Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study.

Harvey B, Lafrance JP, Elftouh N, Vallée M, Laurin LP, Nadeau-Fredette AC

Kidney36020232 citationsOpen Access

DOI: 10.34067/kid.0000000000000098 PMID: 36921585

The effect of renin-angiotensin-aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials.

Alsalemi N, Sadowski CA, Elftouh N, Louis M, Kilpatrick K, Houle SKD, Lafrance JP

BMC nephrology202220 citationsSenior authorOpen Access

DOI: 10.1186/s12882-022-02763-1 PMID: 35484505

Determining Factors Influencing RAS Inhibitors Re-Initiation in ICU: A Modified Delphi Method.

Dahel H, Lafrance JP, Patenaude M, Kilpatrick K, Beaubien-Souligny W, Moreau M, Wang HT

Canadian journal of kidney health and disease20222 citationsOpen Access

DOI: 10.1177/20543581221112266 PMID: 35860649

The Impact of Hypoglycemia on Productivity Loss and Utility in Patients With Type 2 Diabetes Treated With Insulin in Real-world Canadian Practice: Protocol for a Prospective Study.

Lambert-Obry V, Lafrance JP, Savoie M, Lachaine J

JMIR research protocols2022

DOI: 10.2196/35461 PMID: 35343912

Arteriovenous Fistula Creation and Estimated Glomerular Filtration Rate Decline in Advanced CKD: A Matched Cohort Study.

Dupuis MÈ, Laurin LP, Goupil R, Bénard V, Pichette M, Lafrance JP, Elftouh N, Pichette V, Nadeau-Fredette AC

Kidney360202116 citationsOpen Access

DOI: 10.34067/kid.0005072020 PMID: 35368820

Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec's Reference Center.

Leclerc S, Benkirane K, Nadeau-Fredette AC, Elftouh N, Lafrance JP, Pichette V, Royal V, Lamarche C, Laurin LP

Canadian journal of kidney health and disease20211 citationsOpen Access

DOI: 10.1177/20543581211052729 PMID: 34721885

Acute kidney injury in critically ill children and 5-year hypertension.

Hessey E, Perreault S, Roy L, Dorais M, Samuel S, Phan V, Lafrance JP, Zappitelli M

Pediatric nephrology (Berlin, Germany)202025 citations

DOI: 10.1007/s00467-020-04488-5 PMID: 32162099

Use of Desmopressin Prior to Kidney Biopsy in Patients With High Bleeding Risk.

Leclerc S, Nadeau-Fredette AC, Elftouh N, Lafrance JP, Pichette V, Laurin LP

Kidney international reports202024 citationsOpen Access

DOI: 10.1016/j.ekir.2020.05.006 PMID: 32775817

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Jean-Philippe Lafrance

Research

Latest papers

Latest funding

Is health-related quality of life trajectory associated with dialysis modality choice in advanced chronic kidney disease?

Designing and validating a clinical decision support algorithm for diabetic nephroprotection in older patients.

Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study.

The effect of renin-angiotensin-aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials.

Determining Factors Influencing RAS Inhibitors Re-Initiation in ICU: A Modified Delphi Method.

The Impact of Hypoglycemia on Productivity Loss and Utility in Patients With Type 2 Diabetes Treated With Insulin in Real-world Canadian Practice: Protocol for a Prospective Study.

Arteriovenous Fistula Creation and Estimated Glomerular Filtration Rate Decline in Advanced CKD: A Matched Cohort Study.

Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec's Reference Center.

Acute kidney injury in critically ill children and 5-year hypertension.

Use of Desmopressin Prior to Kidney Biopsy in Patients With High Bleeding Risk.

The KIdney aNd blooD prESsure ouTcomes - Determining best fOllow-up in hospitalized Children (KINDEST-DOC) study: A national study of the FILTR-CKD study group

Impact of COVID-19 on Patients Receiving Hemodialysis: The Quebec Renal Network (QRN) COVID-19 Study

Facilitating Cluster Trials in Dialysis: A National Workshop of Key Stakeholders

Frequent collaborators

Vincent Pichette

Louis-Philippe Laurin

Annie Nadeau-Fredette

Louise Roy

Elham Rahme

Caroline Lamarche

Simon Leclerc

Susan Samuel

Michael Zappitelli

Adeera Levin

Rémi Goupil

Kelley Kilpatrick

Duy Tran

Georges Ouellet

Virginie Royal

Katherine Desforges

Anne Boucher

Suzon Collette

Suzanne Morin

Manish Sood

William Beaubien-Souligny

Cheryl Sadowski

Josée Bouchard

Alain Bonnardeaux

Jacques Le Lorier

Barthelemy Defo

Michelle Savoie

Lucie Richard

Pierre Fournier

Marie Hatem

Joanne Kappel

Evelyne Rey

Habib Mawad

Marie-Chantal Fortin

Carl-Ardy Dubois

Scott Klarenbach

Jean-François Cailhier

Amber Molnar